A promising new treatment for infants with Noonan syndrome

http://bit.ly/2LefK3m Infants less than six months old with Noonan Syndrome, hypertrophic cardiomyopathy and congestive heart failure normally have a poor prognosis, with a one-year survival rate of 34 percent. In the new study, doctors used Trametinib to try to treat NS in two patients. They observed dramatic improvement of clinical and cardiac status in the patients only three months after treatment.

New 3D microscope visualizes fast biological processes better than ever

http://bit.ly/2GKK9Rt Researchers have combined their expertise to develop a new type of microscope. The revolutionary new light-field microscopy system makes it possible to study fast biological processes, creating up to 200 3D images per second. Initial tests have already delivered new insights into the movement of blood cells in a heart.

Watchful waiting reasonable for patients with diabetic macular edema and good vision

http://bit.ly/2Vwc0hH People with good vision despite having center-involved diabetic macular edema can safely forego immediate treatment of their eye condition as long as they are closely monitored, and treatment begins promptly if vision worsens, according to clinical trial results.